Cetera Advisor Networks’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,528
Closed -$245K 2153
2021
Q4
$245K Buy
26,528
+8,590
+48% +$91.2K ﹤0.01% 1735
2021
Q3
$255K Buy
17,938
+823
+5% +$12.8K ﹤0.01% 1642
2021
Q2
$284K Buy
+17,115
New +$319K ﹤0.01% 1535

Other funds holding ORGO

Cetera Advisor Networks's ORGO Position: Q1 2022 in Review

Cetera Advisor Networks sold out of Organogenesis Holdings (ORGO) in Q1 2022, closing a stake of 26,528 shares — an estimated $245K sold.

Cetera Advisor Networks first reported a position in ORGO in Q2 2021 and held it in 3 quarters. The position peaked at $284K in Q2 2021. 156 funds tracked by Wall St. Rank hold ORGO as of Q1 2022.

  • Cetera Advisor Networks reported no remaining Organogenesis Holdings position as of Q1 2022 after selling out during the quarter.
  • Cetera Advisor Networks sold 26,528 Organogenesis Holdings shares in Q1 2022, an estimated $245K.
  • Cetera Advisor Networks first reported a position in Organogenesis Holdings in Q2 2021 and held it in 3 quarters.
  • Cetera Advisor Networks's Organogenesis Holdings position peaked at $284K in Q2 2021.
  • 156 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2022.

Based on Cetera Advisor Networks's 13F filing for Q1 2022, filed 12 May 2022.